Maximus (MMS)
Runs tech-enabled health, human-services, clinical, and technology programs for governments.
$55.18
After hours−0.08 (−0.14%)
At close$55.26(−1.27%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Sep 2023 | Q1 FY24Dec 2023 | Q2 FY24Mar 2024 | Q3 FY24Jun 2024 | Q4 FY24Sep 2024 | Q1 FY25Dec 2024 | Q2 FY25Mar 2025 | Q3 FY25Jun 2025 | Q4 FY25Sep 2025 | Q1 FY26Dec 2025 | Q2 FY26Mar 2026 | Q3 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,260 | 1,327 | 1,348 | 1,315 | 1,316 | 1,403 | 1,362 | 1,348 | 1,318 | 1,345 | 1,306 | 1,279 |
| Cost of revenue | 993 | 1,050 | 1,052 | 1,006 | 1,037 | 1,124 | 1,046 | 1,012 | 1,008 | 1,047 | 984 | 930 |
| Gross profit | 267 | 277 | 296 | 309 | 279 | 279 | 316 | 337 | 311 | 298 | 322 | 349 |
| 170 | 167 | 168 | 167 | 166 | 153 | 163 | 171 | 187 | 161 | 173 | 187 | |
| Selling, general & administrative | 170 | 167 | 168 | 167 | 166 | 153 | 163 | 171 | 187 | 152 | 173 | 0 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 187 |
| Operating income | 97 | 109 | 128 | 142 | 113 | 125 | 153 | 166 | 124 | 137 | 148 | 161 |
| −18 | −24 | −20 | −22 | −20 | −56 | −21 | −23 | −23 | −11 | −22 | −23 | |
| Interest expense | 21 | 22 | 20 | 21 | 20 | 18 | 21 | 23 | 22 | 19 | 24 | 24 |
| Other non-operating income | −2 | 2 | −1 | 1 | 0 | 39 | −1 | 0 | 1 | −8 | −2 | −1 |
| Income before tax | 78 | 86 | 108 | 120 | 93 | 69 | 132 | 143 | 100 | 126 | 127 | 138 |
| Income tax expense | 19 | 21 | 27 | 31 | 20 | 28 | 36 | 37 | 25 | 32 | 28 | 35 |
| Net income from continuing operations | 59 | 64 | 81 | 90 | 73 | 41 | 97 | 106 | 75 | 94 | 98 | 104 |
| Net income | 59 | 64 | 81 | 90 | 73 | 41 | 97 | 106 | 75 | 94 | 98 | 104 |
| EPS, basic | $0.97 | $1.05 | $1.31 | $1.47 | $1.20 | $0.69 | $1.70 | $1.87 | $1.34 | $1.71 | $1.81 | $1.96 |
| EPS, diluted | $0.96 | $1.04 | $1.31 | $1.46 | $1.19 | $0.69 | $1.69 | $1.86 | $1.32 | $1.70 | $1.80 | $1.95 |
| Weighted average shares, basic | 61 | 61 | 61 | 61 | 61 | 60 | 57 | 57 | 56 | 55 | 55 | 53 |
| Weighted average shares, diluted | 62 | 62 | 62 | 61 | 61 | 60 | 57 | 57 | 57 | 55 | 55 | 53 |
| EBITDA | 140 | 139 | 158 | 172 | 146 | 118 | 186 | 198 | 160 | 179 | 183 | 209 |
| Depreciation & amortization | 42 | 32 | 30 | 31 | 33 | 31 | 32 | 33 | 37 | 33 | 33 | 47 |
| EBIT | 99 | 107 | 128 | 141 | 113 | 86 | 154 | 166 | 123 | 145 | 150 | 162 |
